Sensitization of cancer cells for chemo/immuno/radio-therapy
著者
書誌事項
Sensitization of cancer cells for chemo/immuno/radio-therapy
（Cancer drug discovery and development）
Humana Press, c2008
大学図書館所蔵 件 / 全3件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This book reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. It also introduces several current approaches developed by established investigators that are aimed at overcoming resistance. This is the first volume to compile studies on tumor cell sensitization. It will prove useful for students, scientists, clinicians and pharmaceutical companies.
目次
- Table of Contents Preface Part I. Sensitization via membrane-bound receptors 1. Sensitization of epithelial cancer cells with human monoclonal antibodies Peter Vollmers and Stephanie Brandlein 2. Targeting the transferrin receptor to overcome resistance to anti-cancer agents Tracy R. Daniels, Isabel I. Neacato, Gustavo Helguera, Manuel L. Penichet 3. Chemo-immunosensitization of resistant B-NHL as a result of rituximab (anti CD20 mAb)-mediated inhibition of cell survival signaling pathways Benjamin Bonavida, Ali R. Jazirehi, Mario I. Vega, Sara Huerta-Yepez, Kazuo Umezawa, and Eriko Suzuki 4. Agents that regulate DR5 and sensitivity to TRAIL Tatsushi Yoshida and Toshiyuki Sakai 5. Proteasome inhibition: Potential for sensitization of immune effector mechanisms in cancer Milad Motarjemi, William H.D. Hallett, Minghui Li, and William J. Murphy Part II. Sensitization via inhibition of cell survival pathways (excluding apoptotic signaling pathways) 6. Angiogenesis inhibitors as chemosensitizing agents for the treatment of metastatic disease Giulio Francia, Urban Emmenegger, and Robert S. Kerbel. 7. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK and P13K/Akt pathways to sensitize cancer cells to therapy James A. McCubrey, Richard A. Franklin, Fred E. Bertrand, Jackson R. Taylor, illiam H. Chappell, Melissa L. Midgett, Ellis WT. Wong, Stephen L. Abrams, ristin M. Stadelman, Negin Misaghian, Dale E. Lugwid, Jorg Basecke, Massimo ibra, Franca Stivala, Michele Milella, Agostino Tafuri, Alberto M. Martelli, aolo Lungi, Antonio Bonati, David M. Terrian, Brian D. Lehmann, and Linda S. Steelman 8. Histone deacetylase inhibitors and anti-cancer activity Roberto R. Rosato and Steven Grant 9. Eicosanoids and resistance of cancer cells to chemotherapeutic agents Andrey Sorokin Part III. Sensitization via transcription factors 10. The RKIP and STAT3 axis in cancer chemotherapy: opposites attract Devasis Chatterjee, Edmond Sabo, Murray B. Resnick, Kam C. Yeung, and Y. Eugene Chin 11. Targeting transcription factors with decoy oligonucelotides: modulation of the expression of genes involved in chemotherapy resistance of tumor cells Roberto Gambari 12. p53 inhibitors as cancer sensitizing agents Flavio Maina and Rosanna Dono 13. Nitric Oxide-Induced Immunosensitization to Apoptosis by Fas-L and TRAIL Benjamin Bonavida, Sara Huerta-Yepez, Mario I. Vega, Demetrios A. Spandidos and Stravoula Baritaki 14. Natural agents that can sensitize tumor cells to chemotherapy and radiation therapy Ganesh Jagetia, Sunil Krishnan, and Bharat B. Aggarwal Part IV. Sensitization via targeting apoptotic pathways 15. Inhibitors of the Bcl-2 protein family as sensitizers to anticancer agents Daniel E. Johnson 16. Therapeutic targeting of apoptosis in cancer Timothy R. Wilson, Daniel B. Longley, and Patrick G. Johnston 17. Peptides and peptidomimetics as cancer therapy sensitizing agents Shantanu Banerji, Sudharsana Rao Ande, Subbareddy Maddika, Versha Banerji, Iran Rashedi, Neil W. Owens, Anne Zuse, Frank Schweizer, and Marek Los 18. Nonpeptidic mimetics as cancer sensitizing agents Ruud P.M. Dings, Mark Klein, and Kevin H. Mayo 19. Sensitization of cancer cells to cancer therapies by isoflavone and its synthetic derivatives Fazlul H. Sarkar and Yiwei Li 20. Antisense oligonucelotides and siRNA as specific inhibitors of gene expression: mechanisms of action and therapeutic potentitial
- AS-ODN and siRNA: mechanisms and therapeutic potential Yvonne Foerster and Bernd Schwenzer Part V. Sensitization tailored to individual patients 21. DNA
「Nielsen BookData」 より
